Mary M. Moran

Neglected Disease Research and Development: How Much Are We Really Spending?

Mary M. Moran, Javier Guzmán, A. L. Ropars et al. · PLoS Medicine · 2009 · 247 citations · Full text

Veterinary Medicine, Health Policy, Infectious Diseases +12

A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need

Mary M. Moran · PLoS Medicine · 2005 · 184 citations · Full text

Medicine, Pharmacology, Drug Discovery +6

Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2

Manuela Di Fusco, Mary M. Moran, Alejandro Cané et al. · Journal of Medical Economics · 2021 · 57 citations · Full text

Medicine, Immunology, Infectious Diseases +13

The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths

Teresa K. Yamana, Marta Galanti, Sen Pei et al. · PLoS ONE · 2023 · 46 citations · Full text

Public Affairs, Infectious Diseases, Preventive Medicine +16

Registering New Drugs for Low-Income Countries: The African Challenge

Mary M. Moran, Nathalie Strub‐Wourgaft, Javier Guzmán et al. · PLoS Medicine · 2011 · 43 citations · Full text

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +11